MedKoo Cat#: 592400 | Name: Hydroxyphenamate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Hydroxyphenamate is a biochemical.

Chemical Structure

Hydroxyphenamate
Hydroxyphenamate
CAS#50-19-1

Theoretical Analysis

MedKoo Cat#: 592400

Name: Hydroxyphenamate

CAS#: 50-19-1

Chemical Formula: C11H15NO3

Exact Mass: 209.1052

Molecular Weight: 209.25

Elemental Analysis: C, 63.14; H, 7.23; N, 6.69; O, 22.94

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Hydroxyphenamate; NSC 108034; NSC-108034
IUPAC/Chemical Name
1,2-Butanediol, 2-phenyl-, 1-carbamate
InChi Key
WAFIYOULDIWAKR-UHFFFAOYSA-N
InChi Code
InChI=1S/C11H15NO3/c1-2-11(14,8-15-10(12)13)9-6-4-3-5-7-9/h3-7,14H,2,8H2,1H3,(H2,12,13)
SMILES Code
CCC(O)(C1=CC=CC=C1)COC(N)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 209.25 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Gurney BF. Chemotherapy in dental practice barbiturate substitures. 4. Hydroxyphenamate and oxanamide. Dent Dig. 1970 Feb;76(2):112-3. PubMed PMID: 5262943. 2: Miller MJ, Shettel R, Fiedler HT. Chronic toxicologic evaluation of hydroxyphenamate and possible synergism with phenothiazines. Psychosomatics. 1965 Sep-Oct;6(5):340-2. PubMed PMID: 5319246. 3: ESSMAN WB. HYDROXYPHENAMATE-INDUCED ATTENUATION OF CONDITIONED AVOIDANCE BEHAVIOR IN MICE. Arch Int Pharmacodyn Ther. 1964 Oct 1;151:510-4. PubMed PMID: 14228064. 4: GREENWALD AS. RELIEF OF TENSION IN DENTAL PATIENTS: A CONTROLLED STUDY WITH HYDROXYPHENAMATE. J Am Dent Assoc. 1964 May;68:708-14. PubMed PMID: 14143882. 5: HSU JJ, BRAUN RA, DOMINO EF, LOWINGER P, SCHORER C, BRUCK M. CLINICAL EVALUATION OF HYDROXYPHENAMATE IN PSYCHOTIC PATIENTS. Dis Nerv Syst. 1963 Dec;24:750-1. PubMed PMID: 14096608. 6: HUFFMAN WJ, FLORIO AE, PAYNE JL, BOYS FE. The influence of two selected tranquilizers on driving skills. Am J Psychiatry. 1963 Mar;119:885-6. PubMed PMID: 13955504. 7: MEYER J, BUSWELL M. Impressions of the possible effects of a new tranquilizer, hydroxyphenamate. Am J Psychiatry. 1962 Nov;119:463-4. PubMed PMID: 13935281. 8: ABBOTT JA, SCHOLL ML, SCHWAB RS, ENGLAND AC Jr. A report on the apparent anticonvulsant effect of hydroxyphenamate (Listica). Dis Nerv Syst. 1962 Sep;23:519-21. PubMed PMID: 13858828. 9: HUBATA JA, HECHT RA. Review of clinical use of hydroxyphenamate in 1759 patients. Clin Med (Northfield). 1962 Jul;69:1594-8. PubMed PMID: 15445778. 10: MCLAUGHLIN BE. Symposium on hydroxyphenamate. Introduction. Dis Nerv Syst. 1961 Sep;22(9)Suppl:5-6. PubMed PMID: 13774073. 11: GREENSPAN EB. Use of hydroxyphenamate in some forms of cardiovascular disease. Dis Nerv Syst. 1961 Sep;22(9)Suppl:33-5. PubMed PMID: 13708349. 12: GOULDMAN C, LUNDE F, DAVIS J. Clinical trial of hydroxyphenamate (Listica) in alcoholic patients. Dis Nerv Syst. 1961 Sep;22(9)Suppl:44-6. PubMed PMID: 13707512. 13: CAHN MM, LEVY EJ. Use of hydroxyphenamate (Listica) in dermatologic therapy. Dis Nerv Syst. 1961 Sep;22(9)Suppl:47-9. PubMed PMID: 13689809. 14: CAHN B. Effect of hydroxyphenamate in the treatment of mild and moderate anxiety states. (A double blind study with crossover pattern). Dis Nerv Syst. 1961 Sep;22(9)Suppl:30-2. PubMed PMID: 13689796. 15: ALEXANDER L. Effect of hydroxyphenamate on the conditional psychogalvanic reflex in man. Dis Nerv Syst. 1961 Sep;22(9)Suppl:17-24. PubMed PMID: 13682351.